EPISODE · Mar 8, 2011 · 6 MIN
MBCC: Genomic Profiles
from Cancer Network Podcasts · host Cancer Network
Are genomic profiles refined enough that they should be used routinely to determine which breast cancer patients should receive adjuvant therapy? According to J. Michael Dixon, MD, who will be presenting the contra argument to this question in a debate at the Miami Breast Cancer Conference this week, the answer is: Not yet.
Embed this episode
NOW PLAYING
MBCC: Genomic Profiles
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.